Semiconductors Overtake Pharmaceuticals in LexisNexis' 2026 Top 100 Global Innovators
Event summary
- LexisNexis named its 2026 Top 100 Global Innovators, shifting leadership from pharmaceuticals to semiconductors.
- Semiconductors lead with 14 honorees, up from pharmaceuticals' previous dominance, reflecting industry-specific innovation trends.
- US companies dominate the list with 46 honorees, while Asia shows balanced representation across China, Korea, and Japan.
- 21 new entrants include startups and conglomerates like Adeia, Flagship Pioneering, Airbus, Safran, Fujitsu, and LONGi Green Energy.
- LexisNexis' Patent Asset Index methodology analyzed 17 million global patent families to identify leaders in innovation.
The big picture
LexisNexis' 2026 Top 100 Global Innovators highlights a strategic shift from pharmaceuticals to semiconductors, reflecting broader industry trends in patent-driven innovation. The dominance of US companies underscores the country's leadership in high-impact research, while Asia's balanced representation signals growing competition. This ranking emphasizes the importance of high-quality patent portfolios in driving competitive advantage and revenue, with smaller companies demonstrating outsized strategic relevance through focused capabilities.
What we're watching
- Industry Leadership
- Whether semiconductors can sustain their lead over pharmaceuticals in future innovation rankings.
- Geographic Shifts
- The pace at which Asia, particularly China and Korea, continues to gain representation in global innovation.
- Startup Impact
- How new entrants like Adeia and Flagship Pioneering influence the competitive landscape with targeted growth strategies.
Related topics